Telos Capital Management, Inc. Abb Vie Inc. Transaction History

Telos Capital Management, Inc.

$937 Million
Q3 2024

A detailed history of Telos Capital Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Telos Capital Management, Inc. holds 24,331 shares of ABBV stock, worth $4.38 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares

24,331

Previous 24,973 2.57%

Holding current value

$4.38 Million

Previous $4.28 Million 12.16%

% of portfolio

0.51%

Previous 0.48%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$163.84 - $199.33 $105,185 - $127,969	-642 Reduced 2.57%	24,331 $4.8 Million
Q2 2024 Jul 31, 2024	SELL	$154.79 - $180.76 $70,274 - $82,065	-454 Reduced 1.79%	24,973 $4.28 Million
Q1 2024 Apr 24, 2024	SELL	$159.82 - $182.1 $4.12 Million - $4.7 Million	-25,808 Reduced 50.37%	25,427 $4.63 Million
Q4 2023 Jan 30, 2024	BUY	$137.6 - $154.97 $60,131 - $67,721	437 Added 0.86%	51,235 $7.94 Million
Q3 2023 Nov 01, 2023	BUY	$133.59 - $154.65 $120,231 - $139,185	900 Added 1.8%	50,798 $7.57 Million
Q2 2023 Jul 20, 2023	SELL	$132.51 - $164.9 $64,797 - $80,636	-489 Reduced 0.97%	49,898 $6.72 Million
Q1 2023 Apr 27, 2023	SELL	$144.61 - $166.54 $571,498 - $658,166	-3,952 Reduced 7.27%	50,387 $8.03 Million
Q4 2022 Jan 27, 2023	BUY	$138.31 - $165.87 $27,523 - $33,008	199 Added 0.37%	54,339 $0
Q3 2022 Oct 31, 2022	BUY	$134.21 - $153.93 $22,010 - $25,244	164 Added 0.3%	54,140 $7.27 Million
Q2 2022 Aug 08, 2022	SELL	$137.62 - $174.96 $77,480 - $98,502	-563 Reduced 1.03%	53,976 $8.27 Million
Q1 2022 May 02, 2022	SELL	$131.98 - $163.75 $232,944 - $289,018	-1,765 Reduced 3.13%	54,539 $8.84 Million
Q4 2021 Jan 21, 2022	SELL	$107.43 - $135.93 $156,847 - $198,457	-1,460 Reduced 2.53%	56,304 $7.62 Million
Q3 2021 Oct 19, 2021	SELL	$106.4 - $120.78 $1.6 Million - $1.81 Million	-14,997 Reduced 20.61%	57,764 $6.23 Million
Q2 2021 Jul 15, 2021	SELL	$105.21 - $117.21 $46,292 - $51,572	-440 Reduced 0.6%	72,761 $8.2 Million
Q1 2021 Apr 28, 2021	BUY	$102.3 - $112.62 $3,375 - $3,716	33 Added 0.05%	73,201 $7.92 Million
Q4 2020 Feb 02, 2021	SELL	$80.49 - $108.67 $315,440 - $425,877	-3,919 Reduced 5.08%	73,168 $7.84 Million
Q3 2020 Oct 27, 2020	SELL	$85.91 - $100.83 $39,690 - $46,583	-462 Reduced 0.6%	77,087 $6.75 Million
Q2 2020 Jul 23, 2020	BUY	$73.37 - $98.18 $464,432 - $621,479	6,330 Added 8.89%	77,549 $7.61 Million
Q1 2020 May 01, 2020	BUY	$64.5 - $97.79 $3.14 Million - $4.76 Million	48,658 Added 215.67%	71,219 $5.43 Million
Q4 2019 Jan 23, 2020	BUY	$72.13 - $90.25 $995,538 - $1.25 Million	13,802 Added 157.58%	22,561 $2 Million
Q3 2019 Oct 31, 2019	BUY	$62.98 - $75.72 $551,641 - $663,231	8,759 New	8,759 $664,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Telos Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Telos Capital Management, Inc. with notifications on news.

Account

Telos Capital Management, Inc. Abb Vie Inc. Transaction History